Literature DB >> 15348425

Porous phosphate-gelatine composite as bone graft with drug delivery function.

A Tampieri1, G Celotti, E Landi, M Montevecchi, N Roveri, A Bigi, S Panzavolta, M C Sidoti.   

Abstract

The design and synthesis of porous phosphate-gelatine composite implant which mimicks the structure of natural bone and has drug delivery function is proposed. Gelatine reproducing the proteinaceous part of bone was cross-linked in order to modulate its solubility in the physiologic fluids. The kinetic of gelatine release from ceramic matrix was also evaluated as model of the release of any therapeutic compound which can be loaded into gelatine.

Entities:  

Year:  2003        PMID： 15348425     DOI： 10.1023/a:1024027125003

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN： 0957-4530            Impact factor:   3.896


  9 in total

1.  Porosity-graded hydroxyapatite ceramics to replace natural bone.

Authors:  A Tampieri; G Celotti; S Sprio; A Delcogliano; S Franzese
Journal:  Biomaterials       Date:  2001-06       Impact factor: 12.479

2.  Macroporous hydroxyapatite as alloplastic material for dental applications.

Authors:  G Carotenuto; G Spagnuolo; L Ambrosio; L Nicolais
Journal:  J Mater Sci Mater Med       Date:  1999 Oct-Nov       Impact factor: 3.896

3.  Biodegradable drug delivery system for the treatment of bone infection and repair.

Authors:  L Di Silvio; W Bonfield
Journal:  J Mater Sci Mater Med       Date:  1999 Oct-Nov       Impact factor: 3.896

4.  Macroporous biphasic calcium phosphate ceramics: influence of macropore diameter and macroporosity percentage on bone ingrowth.

Authors:  O Gauthier; J M Bouler; E Aguado; P Pilet; G Daculsi
Journal:  Biomaterials       Date:  1998 Jan-Feb       Impact factor: 12.479

5.  Drawn gelatin films with improved mechanical properties.

Authors:  A Bigi; B Bracci; G Cojazzi; S Panzavolta; N Roveri
Journal:  Biomaterials       Date:  1998-12       Impact factor: 12.479

6.  Chemical and swelling evaluations of amino group crosslinking in gelatin and modified gelatin matrices.

Authors:  C M Ofner; W A Bubnis
Journal:  Pharm Res       Date:  1996-12       Impact factor: 4.200

7.  Mechanical and thermal properties of gelatin films at different degrees of glutaraldehyde crosslinking.

Authors:  A Bigi; G Cojazzi; S Panzavolta; K Rubini; N Roveri
Journal:  Biomaterials       Date:  2001-04       Impact factor: 12.479

8.  Characterization of porous hydroxyapatite.

Authors:  K A Hing; S M Best; W Bonfield
Journal:  J Mater Sci Mater Med       Date:  1999-03       Impact factor: 3.896

9.  Biodegradable microspheres: a new delivery system for growth hormone.

Authors:  L Di Silvio; N Gurav; M V Kayser; M Braden; S Downes
Journal:  Biomaterials       Date:  1994-09       Impact factor: 12.479
  9 in total
  4 in total

Review 1.  Evolving application of biomimetic nanostructured hydroxyapatite.

Authors:  Norberto Roveri; Michele Iafisco
Journal:  Nanotechnol Sci Appl       Date:  2010-11-09

Review 2.  Organic-inorganic composites for bone drug delivery.

Authors:  Chidambaram Soundrapandian; Biswanath Sa; Someswar Datta
Journal:  AAPS PharmSciTech       Date:  2009-10-20       Impact factor: 3.246

3.  Biomorphous porous hydroxyapatite-ceramics from rattan (Calamus Rotang).

Authors:  Christiane Eichenseer; Julia Will; Markus Rampf; Süsen Wend; Peter Greil
Journal:  J Mater Sci Mater Med       Date:  2009-08-23       Impact factor: 3.896

4.  Controlled release of vancomycin from cross-linked gelatine.

Authors:  Domenico Tigani; Carola Zolezzi; Federico Trentani; Alessandro Ragaini; Michele Iafisco; Silvia Manara; Barbara Palazzo; Norberto Roveri
Journal:  J Mater Sci Mater Med       Date:  2007-10-04       Impact factor: 3.896
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.